Latest Videos

Latest News

Bristol Myers Squibb Acquires Mirati Therapeutics for up to $5.8 Billion

Bristol Myers Squibb Acquires Mirati Therapeutics for up to $5.8 Billion

October 12th 2023

Mirati’s focus on breakthrough cancer treatments will bolster Bristol Myers Squibb’s oncology portfolio.

Salipro Biotech and Icosagen to Collaborate on Antibody Discovery

Salipro Biotech and Icosagen to Collaborate on Antibody Discovery

October 12th 2023

Salipro Biotech and Icosagen have entered into a multi-target collaboration to discover and characterize monoclonal antibodies.

BIOVECTRA in Tech Transfer Agreement with Acuitas Therapeutics for LNP Delivery System

BIOVECTRA in Tech Transfer Agreement with Acuitas Therapeutics for LNP Delivery System

October 11th 2023

Under this agreement, Acuitas Therapeutics’ LNP technology platform will be transferred to BIOVECTRA for use in manufacturing mRNA-based therapies.

Roche to Develop Two Novel RNA-targeted Programs from Ionis for CNS Diseases

Roche to Develop Two Novel RNA-targeted Programs from Ionis for CNS Diseases

October 11th 2023

Roche will gain exclusive worldwide rights to develop, manufacture, and commercialize Ionis’ investigational RNA-based therapeutic candidates for Alzheimer's and Huntington's disease.

Advent International, Warburg Pincus Complete $4.25 Billion Acquisition of Baxter’s BioPharma Solutions Business

Advent International, Warburg Pincus Complete $4.25 Billion Acquisition of Baxter’s BioPharma Solutions Business

October 2nd 2023

The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.

Sartorius and SPARTA Biodiscovery Partner on Novel Nanoparticle Analysis Platform

Sartorius and SPARTA Biodiscovery Partner on Novel Nanoparticle Analysis Platform

September 29th 2023

Under the partnership, Sartorius will leverage SPARTA Biodiscovery’s technology to accelerate development of nanoparticles used for drug delivery.

MilliporeSigma Opens Two New GMP Manufacturing Sites in Germany for mRNA Production

MilliporeSigma Opens Two New GMP Manufacturing Sites in Germany for mRNA Production

September 28th 2023

With the two new GMP-grade mRNA manufacturing sites in Germany, MilliporeSigma can now offer fully integrated mRNA services.

Genentech Partners with Orionis Biosciences to Discover and Develop Molecular Glue Class Medicines

Genentech Partners with Orionis Biosciences to Discover and Develop Molecular Glue Class Medicines

September 20th 2023

Under the collaboration, Orionis will receive $47 million upfront to leverage its Allo-Glue platform to discover small-molecule monovalent glues.

CN Bio and LifeNet Health LifeSciences Partner to Supply Pre-Validated Cells

CN Bio and LifeNet Health LifeSciences Partner to Supply Pre-Validated Cells

September 20th 2023

CN Bio and LifeNet Health LifeSciences have teamed up to provide direct access to a portfolio of highly characterized hepatic cells for the creation of advanced liver-on-a-chip assays.

Illumina Establishes New Center in India to Expand Genomics Capabilities

Illumina Establishes New Center in India to Expand Genomics Capabilities

September 7th 2023

Illumina’s new solutions center in Bengaluru, India, will expand access to genomics in the country.